BIO · NYSE · Life Sciences Tools & Services
Life Sciences Tools & Services company based in Hercules, California.
In the last 90 days, no insider of Bio-Rad Laboratories reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$379.82
Last 12 months
Not enough history
Market value
Not available
Revenue
$651M
−0.1% vs the same quarter a year earlier
Free cash flow, last 12 months
$353M
This quarter $66.7M, a year earlier $70.8M
Net debt
$687M
Debt $1.2B, cash $517M, at Jun 30, 2026
Net income, last 12 months
$222M
Operating profit covers interest 1.1x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 4, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$2.58B
+0.7% vs the year before
Net income, fiscal 2025
$760M
As reported in the annual filing
Shares outstanding
Not available
Reported per share class only, with no single total
In fiscal 2025 the company spent $296M buying back its own shares. Cash actually paid, from its cash-flow statement.
Stock since the trade +55.8% · S&P 500 +4.8% · to Oct 5
Bio-Rad Laboratories's President, CDG sold $136K of Bio-Rad Laboratories shares. Nobody planned it ahead of time.
Stock since the trade +23.9% · S&P 500 +15.6% · to Oct 5
Bio-Rad Laboratories's President, LSG sold $214K of Bio-Rad Laboratories shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $309.17 on Oct 6, 2025 to $379.82 on Oct 5, 2026 (+22.9%). Disclosed activity in the last 12 months: 0 insider purchases, 2 insider sales, 0 Congress purchases, 0 Congress sales.
